1
|
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
|
Lancet
|
2012
|
5.12
|
2
|
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
|
Gastroenterology
|
2011
|
3.81
|
3
|
Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
|
Gastroenterology
|
2013
|
3.45
|
4
|
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
|
Gastroenterology
|
2011
|
3.08
|
5
|
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
|
Gastroenterology
|
2006
|
2.91
|
6
|
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
|
N Engl J Med
|
2011
|
2.44
|
7
|
A simple biological score for predicting low risk of short-term relapse in Crohn's disease.
|
Inflamm Bowel Dis
|
2006
|
1.70
|
8
|
Saccharomyces boulardii does not prevent relapse of Crohn's disease.
|
Clin Gastroenterol Hepatol
|
2013
|
1.50
|
9
|
Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999).
|
J Pediatr Gastroenterol Nutr
|
2005
|
1.45
|
10
|
Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study.
|
Eur J Gastroenterol Hepatol
|
2005
|
1.36
|
11
|
The natural history of pediatric ulcerative colitis: a population-based cohort study.
|
Am J Gastroenterol
|
2009
|
1.29
|
12
|
Is stenting as "a bridge to surgery" an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis.
|
Ann Surg
|
2013
|
1.23
|
13
|
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
|
Gut
|
2013
|
1.22
|
14
|
Colonic pseudolipomatosis: clinical, endoscopical and pathological features in nine cases.
|
Gastroenterol Clin Biol
|
2006
|
1.17
|
15
|
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol.
|
Gut
|
2012
|
1.03
|
16
|
[Cutaneous fistulization of a liver hydatid cyst].
|
Gastroenterol Clin Biol
|
2005
|
1.00
|
17
|
Groove pancreatitis and pancreatic heterotopia in the minor duodenal papilla.
|
Pancreas
|
2005
|
0.95
|
18
|
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.
|
Inflamm Bowel Dis
|
2014
|
0.95
|
19
|
Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study.
|
J Clin Gastroenterol
|
2005
|
0.93
|
20
|
Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
|
J Gastroenterol Hepatol
|
2009
|
0.90
|
21
|
Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study.
|
Am J Gastroenterol
|
2013
|
0.89
|
22
|
Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study.
|
Inflamm Bowel Dis
|
2011
|
0.89
|
23
|
Endoscopic treatment of chronic pancreatitis.
|
Gastroenterol Clin Biol
|
2005
|
0.89
|
24
|
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2012
|
0.88
|
25
|
Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology.
|
Alcohol Clin Exp Res
|
2010
|
0.84
|
26
|
Complications of portal hypertension in adults: a French consensus.
|
Eur J Gastroenterol Hepatol
|
2005
|
0.83
|
27
|
Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets.
|
Inflamm Bowel Dis
|
2010
|
0.80
|
28
|
Clinical predictors at diagnosis of disabling pediatric Crohn's disease.
|
Inflamm Bowel Dis
|
2012
|
0.79
|
29
|
[Rectal linitis as the first manifestation of a prostatic cancer].
|
Gastroenterol Clin Biol
|
2002
|
0.78
|
30
|
Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study.
|
Inflamm Bowel Dis
|
2016
|
0.78
|
31
|
[Question 5. Management of diverticulitis induced hemorrhage].
|
Gastroenterol Clin Biol
|
2007
|
0.77
|
32
|
Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.
|
Inflamm Bowel Dis
|
2016
|
0.77
|
33
|
[Adenomatous polyposis of the gallbladder and Gardner's syndrome. A rare association].
|
Gastroenterol Clin Biol
|
2007
|
0.76
|
34
|
[Role of TTF-1 immunohistochemistry for the diagnosis of duodenal metastasis of pulmonary adenocarcinoma].
|
Gastroenterol Clin Biol
|
2005
|
0.76
|
35
|
Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study.
|
Inflamm Bowel Dis
|
2013
|
0.76
|
36
|
[Gastric and duodenal ulcers. Gastritis].
|
Rev Prat
|
2009
|
0.75
|
37
|
Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.
|
Eur J Gastroenterol Hepatol
|
2016
|
0.75
|
38
|
[Rectovaginal fistulas in adults].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
39
|
[Delayed recurrence of an endobiliary hepatocellular carcinoma without detectable intra-parenchymatous tumor].
|
Gastroenterol Clin Biol
|
2006
|
0.75
|
40
|
[Surgical management of chronic pancreatitis].
|
Gastroenterol Clin Biol
|
2007
|
0.75
|
41
|
[Overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|
42
|
Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review.
|
Inflamm Bowel Dis
|
2017
|
0.75
|
43
|
[Recommendations for clinical practice for the treatment of ulcerative colitis: general method].
|
Gastroenterol Clin Biol
|
2004
|
0.75
|